Free Trial

Maximus (NYSE:MMS) Upgraded at StockNews.com

Maximus logo with Business Services background

Maximus (NYSE:MMS - Get Free Report) was upgraded by stock analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Thursday.

Maximus Stock Up 3.0 %

Shares of MMS stock traded up $2.13 during trading on Thursday, hitting $72.20. 1,118,699 shares of the company were exchanged, compared to its average volume of 441,236. The business's 50-day simple moving average is $81.04 and its 200 day simple moving average is $86.20. Maximus has a twelve month low of $69.72 and a twelve month high of $93.97. The firm has a market capitalization of $4.35 billion, a price-to-earnings ratio of 14.44 and a beta of 0.73. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49.

Insider Buying and Selling

In other news, insider Michelle F. Link sold 2,208 shares of the company's stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Raymond B. Ruddy acquired 3,490 shares of the business's stock in a transaction that occurred on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the purchase, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 7,063 shares of company stock worth $502,017. Insiders own 1.40% of the company's stock.

Institutional Trading of Maximus

A number of institutional investors and hedge funds have recently modified their holdings of MMS. Inspire Advisors LLC raised its holdings in Maximus by 1.4% in the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider's stock worth $751,000 after acquiring an additional 121 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in shares of Maximus by 4.5% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider's stock worth $272,000 after purchasing an additional 136 shares during the period. Petrus Trust Company LTA lifted its position in shares of Maximus by 2.7% during the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider's stock worth $660,000 after purchasing an additional 185 shares during the last quarter. WR Wealth Planners LLC lifted its position in shares of Maximus by 4.6% during the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider's stock worth $388,000 after purchasing an additional 198 shares during the last quarter. Finally, Holocene Advisors LP boosted its stake in Maximus by 6.5% during the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider's stock valued at $366,000 after purchasing an additional 239 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Did You See Trump’s Bombshell Exec. Order 001? (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Maximus right now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines